Ocugen, Inc. to Present at Upcoming H.C. Wainwright Bioconnect Conference

07.01.2022 - MALVERN, Pa., Jan. 06, 2022 (GLOBE NEWSWIRE) - Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, ...

Related Keywords

India ,Canada ,Bharat ,Shankar Musunuri ,Hc Wainwright Bioconnect ,Drug Administration ,Health Canada ,Ocugen Inc ,Nasdaq ,Bioconnect Conference ,Bharat Biotech ,